ライフサイエンスコーパス: recombinant adenovirus

1 ats using short interfering RNA delivered by recombinant adenovirus.

2 y overexpression of superoxide dismutase via recombinant adenovirus.

3 erexpressed in PA myocytes with the use of a recombinant adenovirus.

4 and CYP7A1 were mediated via infection with recombinant adenoviruses.

5 wley rats received intravenous injections of recombinant adenovirus (1 x 10(9) pfu) containing the tr

6 Recombinant adenovirus (10(13) particles per kilogram) o

7 limb ischemia after intravenous injection of recombinant adenoviruses (10(9) plaque-forming units) en

8 luated the ability of an enteric adenovirus, recombinant adenovirus 41 (rAd41), to elicit intestinal

9 n and immune modulation with a DNA prime and recombinant adenovirus 5 (rAd5) boost vaccine.

10 the rBCG-primed monkeys after boosting with recombinant adenovirus 5 (rAd5) expressing the SIV antig

11 hesized that the efficacy of a DNA prime and recombinant adenovirus 5 boost vaccination regimen (DNA/

12 vaccinia HIV clade B (NYVAC-B) vaccine and a recombinant adenovirus 5-vectored (rAd5-vectored) vaccin

13 We created the recombinant adenoviruses Ad-CMV-GFP-IRES (CGI), Ad-CGI-H

14 is study, we examined whether infection with recombinant adenovirus (Ad) encoding CD154 and/or treatm

15 expressed in lung cancer cell lines through recombinant adenovirus (Ad) infection (Ad-WWOX), and thr

16 Recombinant adenovirus (Ad) is a powerful tool in gene t

17 A recombinant adenovirus (Ad) that expresses ECSOD(R213G)

18 Rh MDDCs were modified by recombinant adenovirus (Ad) transduction and characteriz

19 A recombinant adenovirus (Ad) vector expressing the E2 pro

20 this study, we analyzed interactions between recombinant adenovirus (Ad) vectors and mouse DCs.

21 of 'smart' nanoparticles that are based upon recombinant adenovirus (Ad) vectors and that combine mul

22 he widespread use of replication-incompetent recombinant adenovirus (Ad) vectors as candidate vaccine

23 ma cell lines MDA-MB-468 and SK-BR-3 using a recombinant adenovirus (Ad-IRF-1).

24 To determine the function of Nnat, a recombinant adenovirus (Ad-Nnat) was used to overexpress

25 We then transduced hES2-vCMs with the recombinant adenoviruses (Ad) Ad-PLB or Ad-S16E-PLB to o

26 protein in primary CD4(+) cells by use of a recombinant adenovirus (Ad5/Delta32) was able to down-re

27 To this end, we generated a recombinant adenovirus (AdMYH6) to deliver the full-leng

28 was induced by infection of myocytes with a recombinant adenovirus (AdPak1) containing cDNA for a co

29 Recombinant adenoviruses (Ads) are useful tools in gene

30 catenin/Tcf4 pathway is activated by using a recombinant adenovirus AdTOP-CMV-TK, which carries a her

31 When cells were infected with a recombinant adenovirus (AdV) encoding dominant-negative

32 Recombinant adenovirus (Adv) readily transduces DCs in v

33 arby canine kidney cells, were packaged into recombinant adenovirus and delivered to WIF-B cells in v

34 In chimpanzees successfully vaccinated with recombinant adenovirus and DNA against HCV NS3-5, HCV-sp

35 manipulated by using dominant-negative STAT3 recombinant adenoviruses and a specific inhibitor of MAP

36 ppocampal neurons using nuclear injection or recombinant adenoviruses and examined modulation of ion

37 oned into tetracycline-regulated vectors and recombinant adenoviruses and then studied in colorectal

38 different immunogens--recombinant vaccinia, recombinant adenovirus, and plasmid DNA--on the generati

39 Mice were i.v. infected with a recombinant adenovirus, and within the first 24 h of inf

40 Animals primed by intranasal delivery of recombinant adenoviruses, and boosted by intramuscular i

41 Recombinant adenoviruses are highly efficient and immuno

42 Recombinant adenoviruses are presently being tested clin

43 Replication-defective recombinant adenoviruses are the most widely studied rep

44 ther hand, infection with wild-type GSK3beta recombinant adenovirus-associated virus increased activi

45 production and subsequent administration of recombinant adenovirus-based vaccines to both birds and

46 g with a new technique for labeling axons, a recombinant adenovirus bearing the gene for green fluore

47 Here, we developed recombinant adenoviruses bearing engineered CaMs to faci

48 of mitochondrial superoxide dismutase using recombinant adenovirus blunted lipid peroxidation and at

49 Systemic vaccination with a DNA-prime recombinant adenovirus boost regimen preserved memory CD

50 A prime, protein boost as well as DNA prime, recombinant adenovirus boost regimens expressing these a

51 Rhesus monkeys were immunized with DNA prime-recombinant adenovirus boost vaccines encoding a Gag-Pol

52 ly shown that survival in plasmid DNA-primed/recombinant adenovirus-boosted rhesus monkeys that are c

53 Here, we show that recombinant adenovirus can engineer isolated islets to e

54 r system to generate a replication-deficient recombinant adenovirus capable of simultaneously express

55 A polymerase II and III in cells infected by recombinant adenoviruses carrying ectopic E2E-CAT (chlor

56 tly bound the phosphate moiety, we generated recombinant adenoviruses carrying G6Pase wild type and a

57 Recombinant adenovirus-carrying mPax6 or mPax6Delta286 t

58 Infection with high titers of recombinant adenovirus containing 1.25 kb of the rat CGR

59 A recombinant adenovirus containing a CIC-specific siRNA (

60 f PC in beta-cell function, we constructed a recombinant adenovirus containing a small interfering RN

61 s were infected with a replication-defective recombinant adenovirus containing an inducible KLF4 and

62 r 4 x 10(9) plaque-forming units of E1a-/E3- recombinant adenovirus containing either a rat beta1 Na,

63 cker diabetic fatty (ZDF) (fa/fa) rats, with recombinant adenovirus containing insig-1 or -2 cDNA.

64 Rats were given recombinant adenovirus containing Mn-SOD (Ad.SOD2) or be

65 Recombinant adenovirus containing rat Raldh1 cDNA was ma

66 were made hyperleptinemic by treatment with recombinant adenovirus containing the leptin cDNA.

67 A similar recombinant adenovirus containing the murine IFN-beta (m

68 slets with a cytomegalovirus promoter-driven recombinant adenovirus containing the Nkx6.1 cDNA (AdCMV

69 Recombinant adenoviruses containing 5-HT1A sense and ant

70 osite termination sequence CT were tested in recombinant adenoviruses containing luciferase reporters

71 s were individually expressed in EC by using recombinant adenoviruses, cultured BL cells adhered excl

72 The intradiabodies were expressed from recombinant adenovirus delivered through subtumoral inje

73 Injection of a recombinant adenovirus encoding a constitutively active

74 CypD would alter mPTP in vivo, we injected a recombinant adenovirus encoding C203S-CypD or WT CypD in

75 inistration of tumor cells transduced with a recombinant adenovirus encoding CD40L (AdvCD40L).

76 n contrast, transduction of pericytes with a recombinant adenovirus encoding dominant-negative T-cell

77 extracts confirmed that HAECs treated with a recombinant adenovirus encoding E2F-1 failed to associat

78 irect intramyocardial injections of either a recombinant adenovirus encoding for SCF (Ad.SCF, n=9) or

79 Transduction of kidney cells with recombinant adenovirus encoding Foxo1 results in insulin

80 , murine CD11c(+) DCs were transduced with a recombinant adenovirus encoding full-length murine T-bet

81 We used a recombinant adenovirus encoding full-length murine tumor

82 activation that depends on infection with a recombinant adenovirus encoding herpes simplex virus thy

83 yocardial injection of replication-deficient recombinant adenovirus encoding HGF (n=10) or empty null

84 Murine DC were transduced with a recombinant adenovirus encoding hu gal-1 (gal-1-DC).

85 metabolism in vivo, 1 x 1011 particles of a recombinant adenovirus encoding human EL (AdEL), catalyt

86 fection of two-day-old ksr2(-/-) mice with a recombinant adenovirus encoding human IGF-1.

87 DCs infected with a recombinant adenovirus encoding IL-18 (AdIL18DC) express

88 Infection with a recombinant adenovirus encoding KChAP (Ad/KChAP) increas

89 o myoblasts by quantitative infection with a recombinant adenovirus encoding mouse MyoD.

90 Overexpression of SOCS3 in lung using a recombinant adenovirus encoding murine SOCS3 resulted in

91 Mice received a recombinant adenovirus encoding RelB by intranasal aspir

92 eys through vaccination with plasmid DNA and recombinant adenovirus encoding simian-human immunodefic

93 For functional characterization of Smad4, a recombinant adenovirus encoding Smad4 (Ad-Smad4) was gen

94 ERK1/2 inhibitor PD98059, or infection of a recombinant adenovirus encoding the dominant-negative fo

95 We "painted" recombinant adenovirus encoding the reporter gene Escher

96 Cells transduced with recombinant adenoviruses encoding Bid containing mutatio

97 tact male SD rats with replication-defective recombinant adenoviruses encoding either CYP8b1 or CYP7a

98 1 mouse pancreatic islets were infected with recombinant adenoviruses encoding enhanced green fluores

99 oxycycline-repressible replication-defective recombinant adenoviruses encoding individual epitope-tag

100 In the present studies, recombinant adenoviruses encoding secreted (human apolip

101 Recombinant adenovirus-engineered dendritic cells (Ad.DC

102 that overexpression of wild-type Axl, using recombinant adenoviruses, enhances Axl phosphorylation a

103 largely overcome by prior immunization with recombinant adenovirus, especially for adjuvants that ar

104 In APN-null mice, recombinant adenovirus-expressed APN reduced exaggerated

105 ial injury 1 day after systemic injection of recombinant adenovirus expressing (1) VEGF, (2) VEGF-tra

106 However, when treated with recombinant adenovirus expressing 5-lipoxygenase (Ad5LO)

107 A recombinant adenovirus expressing a constitutively activ

108 uced the embryonic chicken heart in ovo with recombinant adenovirus expressing a death (FasL) ligand.

109 ronary arteries were randomized to receive a recombinant adenovirus expressing a secreted form of TGF

110 Here, we show that vaccination with a recombinant adenovirus expressing a truncated ErbB-2 ant

111 marrow-derived DCs transduced with Ad.Neu, a recombinant adenovirus expressing a truncated neu oncopr

112 We constructed a novel recombinant adenovirus expressing Ad12 E1A (Ad-E1A12) th

113 Cells infected with a recombinant adenovirus expressing constitutively active

114 Using a single intrabursal administration of recombinant adenovirus expressing Cre, we demonstrate th

115 arrow-derived macrophages (BMDMs) by using a recombinant adenovirus expressing dominant-negative Ikap

116 23, transduction of IL-12p40(-/-) DCs with a recombinant adenovirus expressing functional IL-23 resto

117 We produced a recombinant adenovirus expressing GLP-1 (rAd-GLP-1) unde

118 Infection of the hearts with a recombinant adenovirus expressing green fluorescent prot

119 s rapidly expanded following boosting with a recombinant adenovirus expressing HIV-1 Env to gp120-spe

120 ury, we used mouse tail vein injections with recombinant adenovirus expressing HNF-6 complementary DN

121 The investigators constructed a recombinant adenovirus expressing human CD55 (AdCAGCD55)

122 pidemia was corrected by co-infection with a recombinant adenovirus expressing human lipoprotein lipa

123 udy we have transfected rat macrophages with recombinant adenovirus expressing IL-4 (Ad-IL4) and demo

124 Replication-deficient recombinant adenovirus expressing MBP-1 was administered

125 ic potential of MBP-1, replication-deficient recombinant adenovirus expressing MBP-1 was given intrat

126 model, we induced plasma APN levels using a recombinant adenovirus expressing mouse APN (AdAPN) and

127 Recombinant adenovirus expressing NudC (Ad-NudC) was use

128 Microarray analysis of cells infected with a recombinant adenovirus expressing ORF63 showed that tran

129 ly, infection of cultured HepG2 cells with a recombinant adenovirus expressing PGC-1alpha directly ac

130 A recombinant adenovirus expressing PRDM5 caused G2/M arre

131 By infecting pre-fusion osteoclasts using recombinant adenovirus expressing PYK2 and its mutants,

132 rradiated Plasmodium yoelii sporozoites or a recombinant adenovirus expressing the P. yoelii circumsp

133 A recombinant adenovirus expressing the RAP protein induce

134 Immunization of B10.PL mice with a recombinant adenovirus expressing the TCR Vbeta8.2 chain

135 inflammation, were used in conjunction with recombinant adenovirus expressing UGRP1.

136 osteosarcoma cells after their exposure to a recombinant adenovirus expressing wild type BRCA1 (Ad.BR

137 ells transduced with a replication-deficient recombinant adenovirus expressing Z (rAd-Z) are resistan

138 Using recombinant adenoviruses expressing active Notch1 in sma

139 density lipoprotein (HDL), we have generated recombinant adenoviruses expressing apolipoprotein A-I (

140 Recombinant adenoviruses expressing beta-galactosidase,

141 oping and testing tetracycline-regulated and recombinant adenoviruses expressing dominant negative re

142 dothelial cell networks with C3 exoenzyme or recombinant adenoviruses expressing dominant negative Rh

143 d be induced in the absence of IGF action by recombinant adenoviruses expressing MyoD or myogenin, bu

144 an effect that is rescued by infection with recombinant adenoviruses expressing SOD2 and Catalase1.

145 yes were infected with replication-deficient recombinant adenoviruses expressing the beta-galactosida

146 ia was corrected by coinfection of mice with recombinant adenoviruses expressing the mutant apoA-I an

147 obtained by using C57BL/6 mice infected with recombinant adenoviruses expressing the replicating HBV

148 es 261 and 283 were mutated to alanines, and recombinant adenoviruses expressing these apoE mutants w

149 produce mda-7/IL-24 following infection with recombinant adenoviruses expressing this cytokine secret

150 DCs modified by recombinant adenoviruses expressing tumor-associated ant

151 To initiate our studies, we generated three recombinant adenoviruses expressing wild type, constitut

152 3-null H1299 human lung carcinoma cells with recombinant adenoviruses expressing WT p53, p73 or beta-

153 ells were infected with a dominant-negative, recombinant adenovirus, expressing E-cadherin lacking an

154 ent femoral arterial denudation and received recombinant adenovirus, expressing either murine endosta

155 A recombinant adenovirus-expressing hCD59 was generated, a

156 A recombinant adenovirus-expressing Mtb39 (adenoMtb39) was

157 The authors constructed a recombinant adenovirus-expressing murine complement comp

158 rate cohorts also received i.v. injection of recombinant adenovirus-expressing murine GM-CSF (AdGMCSF

159 ransfection, and fibroblasts infected with a recombinant adenovirus-expressing UL142, were used to sc

160 d inside cells using a replication-deficient recombinant adenovirus expression system inhibited LCMV

161 transduction with the replication-deficient recombinant adenovirus expression system to Z and L effe

162 review recent studies combining the tools of recombinant adenovirus for gene delivery, the developmen

163 oses of gag protein, HIV gag plasmid DNA, or recombinant adenovirus-gag.

164 (rAd-IFNalpha/Syn3), a replication-deficient recombinant adenovirus gene transfer vector, for patient

165 se important properties of Vpr, we created a recombinant adenovirus H5.010CMV-vpr (adCMV-vpr) as a to

166 Recombinant adenoviruses have been used as vehicles for

167 In cells infected with either the recombinant adenovirus-HBV or baculovirus-WHV, the repli

168 Increased PTEN expression by recombinant adenovirus in cultured neonatal rat primary

169 rials for cystic fibrosis lung disease using recombinant adenovirus in the early 1990s, the field has

170 as precursors to DCs and also for the use of recombinant adenovirus in vaccines or gene therapy.

171 ular microarrays on a micropillar chip using recombinant adenoviruses in a complementary microwell ch

172 in liver by transducing their expression via recombinant adenoviruses in Agpat2(-/-) mice.

173 Using recombinant adenoviruses in conjunction with surgical an

174 Here we show that WT TAg expressed from recombinant adenoviruses in U2OS cells induced the phosp

175 an, and restoring iPLA(2)betaexpression with recombinant adenovirus increases apoptosis toward WT lev

176 transduced ex vivo by BMP cDNA delivered by recombinant adenoviruses induce bone formation and conve

177 Using recombinant adenovirus-infected ER-negative MDA-MB-231 c

178 ength and truncated forms of the enzyme from recombinant adenovirus-infected human 293 cells.

179 transgenic mice (transthyretin HNF-3beta) or recombinant adenovirus infection (AdHNF3beta), and obser

180 GFAT1 and GFAT1Alt expressed by recombinant adenovirus infection in COS-7 cells displaye

181 previous studies we used transgenic mice or recombinant adenovirus infection to increase hepatic exp

182 We assessed the efficacy and safety of recombinant adenovirus interferon alfa with Syn3 (rAd-IF

183 Overexpression of LAT1 in T24 cells using recombinant adenoviruses led to increased uptake of L-CS

184 We now report that recombinant adenovirus mediated overexpression of the fe

185 and apoptosis in human lung cancer cells by recombinant adenovirus-mediated gene transfer in vitro a

186 In the present study, we transduced recombinant adenovirus-mediated HIF-1alpha in embryonic

187 rogen-independent prostate cancer cells upon recombinant adenovirus-mediated introduction of MBP-1.

188 infection, suggesting that L1 expressed from recombinant adenoviruses might provide protective immuni

189 erexpression of DGAT1 mRNA by >20-fold via a recombinant adenovirus only resulted in approximately 2-

190 e antiviral signals following infection with recombinant adenovirus or by direct nucleic acid transfe

191 Recombinant adenoviruses or baculoviruses expressing rep

192 demonstrated that intratumoral injections of recombinant adenovirus overexpressing p27Kip1 (Adp27) re

193 Administration of a recombinant adenovirus overexpressing SLPI (Adv/SLPI) in

194 Here we show that a recombinant adenovirus-poxvirus prime-boost immunization

195 , followed by two mucosal boosts with either recombinant adenovirus (rAd) or fowlpox virus (rFWPV) ex

196 dminister AERAS-402, a replication-defective recombinant adenovirus (rAd) type 35 expressing Mycobact

197 Although replication-incompetent recombinant adenovirus (rAd) type 5 is a potent vaccine

198 t contribute to the potent immunogenicity of recombinant adenovirus (rAd) vaccine vectors remain larg

199 e that single intranasal immunization with a recombinant adenovirus (rAd) vector encoding both HA of

200 Intramuscular immunization with recombinant adenovirus (rAd) vector-based vaccines expre

201 Recombinant adenovirus (rAd) vectors are being investiga

202 While replication-competent recombinant adenovirus (rAd) vectors can stimulate adeno

203 an populations has led to the development of recombinant adenovirus (rAd) vectors derived from rare A

204 Recombinant adenovirus (rAd) vectors have been shown to

205 at intramuscular injection of nonreplicating recombinant adenovirus (rAd) vectors into rhesus monkeys

206 Rare serotype and chimeric recombinant adenovirus (rAd) vectors that evade anti-Ad5

207 modified for optimal antigen expression and recombinant adenovirus (rAd) vectors, all encoding the g

208 tilizing intramuscularly (i.m.) administered recombinant adenovirus (rAd)-based vectors can induce po

209 vaccines suggest that replication-competent recombinant adenoviruses (rAds) could serve as effective

210 Using recombinant adenovirus (rAdV) as a model for murine APC

211 Biodistribution of recombinant adenovirus (rADV) vectors administered intra

212 Recombinant adenovirus (rAV)-driven c-met overexpression

213 Recombinant adenoviruses replicate only in cancer cells

214 ertk to cultured RCS RPE cells by means of a recombinant adenovirus restored the cells to complete ph

215 ion of primary oligodendrocyte cultures with recombinant adenovirus revealed that expression of Fyn o

216 that therapeutic vaccination with Ad26/MVA (recombinant adenovirus serotype 26 (Ad26) prime, modifie

217 CD8(+) T lymphocyte responses elicited by a recombinant adenovirus serotype 26 (rAd26) vector expres

218 of recombinant adenovirus serotype 5 (rAd5), recombinant adenovirus serotype 28 (rAd28), and recombin

219 In this study, we define a small, recombinant adenovirus serotype 3-derived protein, terme

220 ombinant adenovirus serotype 28 (rAd28), and recombinant adenovirus serotype 35 (rAd35) in associatio

221 tective efficacy of replication-incompetent, recombinant adenovirus serotype 35 (rAd35) vectors expre

222 Intravenous (i.v.) delivery of recombinant adenovirus serotype 5 (Ad5) vectors for gene

223 The Step study of a recombinant adenovirus serotype 5 (Ad5)-based human immu

224 ly increases the immunogenicity of DNA prime-recombinant adenovirus serotype 5 (rAd5) boost and DNA p

225 eutralizing antibodies elicited by DNA prime-recombinant adenovirus serotype 5 (rAd5) boost vaccinati

226 g HIV-1-infected participants who received a recombinant adenovirus serotype 5 (rAd5) HIV-1 gag vacci

227 Use of first-generation recombinant adenovirus serotype 5 (rAd5) platforms faile

228 l activation during the first 2 months after recombinant adenovirus serotype 5 (rAd5) prime or boost

229 Recombinant adenovirus serotype 5 (rAd5) vaccine vectors

230 lication deficient and requires the parental recombinant adenovirus serotype 5 (rAd5) vector for repl

231 nd immunogenicity of a replication-defective recombinant adenovirus serotype 5 (rAd5) vector HIV-1 ca

232 A recombinant adenovirus serotype 5 (rAd5) vector-based va

233 Recombinant adenovirus serotype 5 (rAd5) vector-based va

234 The utility of recombinant adenovirus serotype 5 (rAd5) vector-based va

235 infectivity and cell stimulatory capacity of recombinant adenovirus serotype 5 (rAd5), recombinant ad

236 ysis of the phase 2b Step study evaluating a recombinant adenovirus serotype 5 (rAd5)-based HIV-1 vac

237 yellow fever vaccine virus 17D (rYF17D), and recombinant adenovirus serotype 5 (rAd5).

238 he monkeys were boosted a second time with a recombinant Adenovirus serotype 5 vector containing matc

239 othesis in a relevant primate model, we used recombinant adenovirus serotype 5 vectors expressing SIV

240 When apoM(Q22A) was expressed in vivo, using recombinant adenoviruses, smaller plasma HDL particles a

241 Similarly, treatment of 832/13 cells with a recombinant adenovirus specific to FAS (Ad-siFAS) reduce

242 Boosting with recombinant adenovirus strikingly enhances CD8+, but not

243 cells were pulsed with CFP10 expressed in a recombinant adenovirus, surface adsorbed to microspheres

244 ast carcinoma cell line MDA-MB-468 using the recombinant adenovirus, TGF-beta signaling was restored

245 To test this hypothesis we used a recombinant adenovirus that expresses a human CFTR cDNA

246 We constructed a recombinant adenovirus that expresses ECSOD(R213G).

247 cells fromnormal human breast tissue using a recombinant adenovirus that expresses green fluorescence

248 This article describes a method for making recombinant adenoviruses that efficiently drive expressi

249 n-specific T(CD8(+)) after immunization with recombinant adenoviruses that express antigen driven by

250 Using recombinant adenoviruses that express the preproinsulin

251 Using a recombinant adenovirus to deliver Ag, we demonstrated th

252 ng neonatal rat cardiomyocytes infected with recombinant adenovirus to overexpress tropomodulin.

253 row-derived dendritic cells engineered using recombinant adenovirus to secrete high levels of IL-12p7

254 these cells, they were further modified with recombinant adenoviruses to express high levels of GLUT2

255 and granzyme B cleavage sites, and utilized recombinant adenoviruses to express this protein in hepa

256 ide-binding domains (NBD) of G5 and G8 using recombinant adenoviruses to reconstitute biliary sterol

257 accine constructs: (i) replication-defective recombinant adenovirus type 5 (Ad5) expressing human imm

258 We generated recombinant adenovirus type 5 (Ad5) fiber knob, incorpor

259 An HIV-1 DNA prime vaccine, with a recombinant adenovirus type 5 (rAd5) boost, failed to pr

260 1 Env and Gag-Pol by DNA priming followed by recombinant adenovirus type 5 (rAd5) boosting elicited C

261 me-boost immunization regimens revealed that recombinant adenovirus type 5 (rAd5) prime followed by r

262 f a T-cell-based AIDS vaccine delivered with recombinant adenovirus type 5 (rAd5) vectors showed no e

263 iciency virus (SIV) vaccine trial (DNA prime/recombinant adenovirus type 5 [rAd5] boost) (VRC-10-332)

264 We tested the efficacy of a DNA prime-recombinant adenovirus type 5 boost (DNA/rAd5) vaccine r

265 s were vaccinated via three DNA primes and a recombinant adenovirus type 5 boost (weeks 0, 4, 8, and

266 ium cell line (ARPE-19) were transduced with recombinant adenovirus type 5 carrying mouse Elovl4 and

267 ies such dynamics, using a newly constructed recombinant adenovirus type-5 (Ad5) that expresses enhan

268 Boosting with recombinant Adenovirus type-5 (rAd5) vectors resulted in

269 This study assesses the hypothesis that a recombinant adenovirus vaccine based on the nonhuman pri

270 ter vaccines than r30 with an adjuvant and a recombinant adenovirus vaccine expressing r30.

271 An oral recombinant adenovirus vaccine to influenza was well tol

272 osal challenge following immunization with a recombinant adenovirus vaccine vector.

273 on was obtained in COS-1 cells infected with recombinant adenovirus vector (rAdSERCA).

274 with dendritic cells expressing mEGP from a recombinant adenovirus vector exhibited a muted anti-ade

275 tic levels of HNF-6 either by infection with recombinant adenovirus vector expressing HNF-6 cDNA by g

276 tegy to bypass this escape mechanism using a recombinant adenovirus vector expressing interleukin-12

277 in vivo priming with a replication-defective recombinant adenovirus vector expressing the lymphocytic

278 f ZTA in cell cycle arrest, we constructed a recombinant adenovirus vector expressing ZTA (Ad-ZTA), w

279 In this study, we report the use of a recombinant adenovirus vector to induce regulatory respo

280 tion based on a beta-galactosidase (betagal)-recombinant adenovirus vector.

281 either naive or had been vaccinated using a recombinant, adenovirus-vectored vaccine 2 weeks before

282 Recombinant adenovirus vectors containing vIL-10 (Ad-vIL

283 ally, we demonstrated that immunization with recombinant adenovirus vectors expressing NP and M2 sign

284 PLA2s were expressed in MC-/- or MC+/+ using recombinant adenovirus vectors.

285 protection conferred by a highly protective recombinant adenovirus virus serotype 5 (rAd5) encoding

286 multiclade (A, B, and C) envelope (Env) DNA/recombinant adenovirus virus type 5 (rAd5) vaccine studi

287 Based on the results, a recombinant adenovirus was constructed with the expressi

288 AdhMGP recombinant adenovirus was generated by bacterial transp

289 A recombinant adenovirus was generated with the human rho1

290 get the apoptosis of the OFT cardiomyocytes, recombinant adenovirus was used to express the X-linked

291 Recombinant adenovirus was used to increase HSkMC PGC-1a

292 Using these recombinant adenoviruses, we determined that overexpress

293 Several shRNAs expressed from recombinant adenovirus were developed.

294 Recombinant adenoviruses were generated to express repor

295 Four avian smooth muscle MBS-recombinant adenoviruses were prepared and transfected i

296 Mucosally or parenterally administered recombinant adenoviruses were used in prime-boost regime

297 Here, recombinant adenoviruses were used to express each prote

298 Recombinant adenoviruses were used to overexpress green

299 An intertypic recombinant adenovirus with a serotype 3-like hexon gene

300 e injected with either replication-defective recombinant adenovirus with DNA containing the cytomegal